These PDx anitbodies likely have a range of epitopes, affinities, Fc functions, glycosylations, etc.–all of which could affect activity, but differential activity isn’t likely predictable from preclinical work. And in the real-world setting many of the nuanced differences may disappear in the face of disease complexity.
News 
Market Data 
Discover 
